Safety and Efficacy of Brimonidine Tartrate Posterior Segment Drug Delivery System in Improving Visual Function

Inclusion Criteria: * The macula-off retinal detachment must have been caused by a rupture (rhegmatogenous in etiology) * The repair of the macula-off retinal detachment must have occurred at least 6 months before the Day 1 visit in the study eye * The repair must have been deemed an anatomic success and required no more than one macular re-attachment procedure * The visual acuity score must be between 20/50 and 20/320 in the study eye Exclusion Criteria: * Any sight-threatening ocular condition in the study eye other than the ruptured retinal detachment * Anticipated need for ocular surgery during the 12-month study period * Any injectable, periocular, or intravitreal corticosteroid treatment to study eye within 6 months prior to screening (eg, triamcinolone acetonide) * Any injectable, periocular, or intravitreal anti-VEGF treatment to the study eye within 3 months prior to screening (eg, Avastin or Lucentis) * Any infectious condition in the study eye